Compare CMPX & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CMPX | DSP |
|---|---|---|
| Founded | 2014 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 408.8M | 279.6M |
| IPO Year | 2020 | 2021 |
| Metric | CMPX | DSP |
|---|---|---|
| Price | $2.22 | $13.57 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 8 |
| Target Price | $14.57 | ★ $17.81 |
| AVG Volume (30 Days) | ★ 2.6M | 263.5K |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 157.14 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $344,201,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | $934.41 | $16.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.00 |
| 52 Week Low | $1.61 | $8.11 |
| 52 Week High | $6.88 | $14.80 |
| Indicator | CMPX | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 59.55 |
| Support Level | $1.88 | $10.36 |
| Resistance Level | $2.23 | $14.16 |
| Average True Range (ATR) | 0.12 | 0.57 |
| MACD | -0.02 | 0.08 |
| Stochastic Oscillator | 2.90 | 90.69 |
Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.
Viant Technology Inc is an advertising technology company engaged in providing a cloud-based demand-side platform (DSP) for programmatic advertising. The company enables marketers and advertising agencies to plan, buy, and measure digital advertising campaigns across multiple channels, including connected TV, streaming audio, mobile, desktop, and digital out-of-home. Its platform leverages data integrations and proprietary identity solutions to deliver targeted advertising, audience insights, and performance measurement.